No Data
No Data
Moderna, Inc. (NASDAQ:MRNA) Is Favoured by Institutional Owners Who Hold 68% of the Company
Form 144 | Moderna(MRNA.US) Director Proposes to Sell 1.74 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 10, $Moderna(MRNA.US)$ Director NOUBAR B AFEYAN intends to sell 15,000 shares of its common stock on Jul 10, with a total market value of approximately $1.74 million.
Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures
In a recent development, Flagship Pioneering, the venture capital firm known for backing Moderna (NASDAQ:MRNA) has successfully secured a whopping $3.6 billion in funding.What Happened: Flagship
Redburn Raises Moderna's Price Target to $117 From $116
Moderna (MRNA) has an average outperform rating and a price target range of $62 to $310, according to analysts polled by Capital IQ.Price: 116.68, Change: +0.61, Percent Change: +0.53
Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024
CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report
Moderna (MRNA) Stock Sinks As Market Gains: Here's Why
No Data